DRI Healthcare Trust (DHT-U) - Total Liabilities
Based on the latest financial reports, DRI Healthcare Trust (DHT-U) has total liabilities worth $463.66 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DRI Healthcare Trust - Total Liabilities Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's total liabilities have evolved over time, based on quarterly financial data. See DHT-U working capital ratio to evaluate short-term liquidity relative to the company's equity base.
DRI Healthcare Trust Competitors by Total Liabilities
The table below lists competitors of DRI Healthcare Trust ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
COPLAND ROAD CAPITAL NEW
F:A2P
|
Germany | €347.02 Million |
|
Pharmicell
KO:005690
|
Korea | ₩19.60 Billion |
|
Beijing StarNeto Technology Co Ltd
SHE:002829
|
China | CN¥573.58 Million |
|
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
|
China | CN¥1.57 Billion |
|
Jiahe Foods Industry Co. Ltd.
SHG:605300
|
China | CN¥668.93 Million |
|
Ranpak Holdings Corp
NYSE:PACK
|
USA | $582.60 Million |
|
Santacruz Silver Mining Ltd. Common Shares
NASDAQ:SCZM
|
USA | $237.69 Million |
|
Tilray Inc
TO:TLRY
|
Canada | CA$549.12 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down DRI Healthcare Trust's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DRI Healthcare Trust stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DRI Healthcare Trust's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DRI Healthcare Trust (2020–2024)
The table below shows the annual total liabilities of DRI Healthcare Trust from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $457.34 Million | +67.24% |
| 2023-12-31 | $273.46 Million | +4.74% |
| 2022-12-31 | $261.08 Million | +352.40% |
| 2021-12-31 | $57.71 Million | +15941888.95% |
| 2020-12-31 | $362.00 | -- |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.